Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dr. reddy s s.r.l. - ambrisentan - ambrisentan

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

accord healthcare, s.l.u. - ambrisentan - ambrisentan

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - ambrisentan - ambrisentan

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - ambrisentanum - compresse rivestite con film - filmtablette: ambrisentanum 5 mg, cellulosum microcristallinum, lactosum monohydricum 47.5 mg, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 129 0.022 mg, lecithinum ex soja, pro compresso obducto corresp. natrium 0.339 mg. - polmonare ipertensione arteriosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - ambrisentanum - compresse rivestite con film - filmtablette: ambrisentanum 10 mg, cellulosum microcristallinum, lactosum monohydricum 95 mg, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 129 0.405 mg, lecithinum ex soja, pro compresso obducto corresp. natrium 0.71 mg. - polmonare ipertensione arteriosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - ambrisentanum - compresse rivestite con film - ambrisentanum 5 mg, lactosum monohydricum 95 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, e 171, e 129 0.105 mg, pro compresso obducto. - polmonare ipertensione arteriosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - ambrisentanum - compresse rivestite con film - ambrisentanum 10 mg, lactosum monohydricum 90 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, e 171, e 129 0.4487 mg, pro compresso obducto. - polmonare ipertensione arteriosa - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - ipertensione, polmonare - antipertensivi, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

actelion pharmaceuticals ltd - macitentanum - compresse rivestite con film - filmtablette: macitentanum 10 mg, lactosum monohydricum 38.86 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.21 mg, povidonum k 30, magnesii stearas, polysorbatum 80, Überzug: poly(alcohol vinylicus), talcum, lecithinum ex soja, xanthani gummi, e 171, pro compresso obducto. - polmonare ipertensione arteriosa - synthetika